A detailed history of Td Asset Management Inc transactions in Sanofi stock. As of the latest transaction made, Td Asset Management Inc holds 251,569 shares of SNY stock, worth $12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
251,569
Holding current value
$12 Million
% of portfolio
0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$48.54 - $58.53 $12.2 Million - $14.7 Million
251,569 New
251,569 $14.5 Million
Q2 2020

Aug 13, 2020

SELL
$42.91 - $52.5 $2 Million - $2.45 Million
-46,580 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$38.02 - $51.66 $183,902 - $249,879
4,837 Added 11.59%
46,580 $2.04 Million
Q4 2019

Feb 11, 2020

BUY
$44.25 - $50.86 $148,414 - $170,584
3,354 Added 8.74%
41,743 $2.1 Million
Q3 2019

Nov 07, 2019

SELL
$40.34 - $46.64 $100,930 - $116,693
-2,502 Reduced 6.12%
38,389 $1.78 Million
Q2 2019

Aug 01, 2019

BUY
$40.43 - $44.3 $1,940 - $2,126
48 Added 0.12%
40,891 $1.77 Million
Q1 2019

May 08, 2019

BUY
$40.83 - $45.43 $62,878 - $69,962
1,540 Added 3.92%
40,843 $1.81 Million
Q4 2018

Feb 01, 2019

BUY
$41.48 - $45.59 $923,469 - $1.01 Million
22,263 Added 130.65%
39,303 $1.71 Million
Q3 2018

Nov 01, 2018

SELL
$40.0 - $44.84 $37,840 - $42,418
-946 Reduced 5.26%
17,040 $761,000
Q2 2018

Jul 31, 2018

SELL
$37.63 - $41.22 $208,244 - $228,111
-5,534 Reduced 23.53%
17,986 $720,000
Q1 2018

May 11, 2018

SELL
$38.98 - $45.76 $517,498 - $607,509
-13,276 Reduced 36.08%
23,520 $943,000
Q4 2017

Feb 02, 2018

SELL
$42.86 - $50.61 $5.1 Million - $6.03 Million
-119,090 Reduced 76.4%
36,796 $1.58 Million
Q3 2017

Nov 09, 2017

BUY
$47.04 - $50.34 $7.33 Million - $7.85 Million
155,886
155,886 $7.76 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $120B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.